Drug Discovery

GlycoMar is uniquely focused on the development of novel therapies based on saccharide molecules from marine organisms. These molecules offer a unique therapeutic approach with an excellent safety profile. The company has developed a unique library of polysaccharides and glycosaminoglycans. The molecules have been the subject of compositional analysis and partial structural characterisation. Anti-inflammatory screening has shown a high hit rate of valuable activity, which is being developed for respiratory inflammatory disease in collaboration with a pharmaceutical partner. GlycoMar is seeking partners interested in other therapeutic areas including anti-inflammatory, anti-cancer, anti-coagulant, and anti-infective.

Click here for more information.